Clinical Trial Update: Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating autologous adipose-derived mesenchymal stem cells to treat urinary incontinence after prostatectomy; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cells (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Urinary Incontinence | Phase 1, Phase 2 | Status: COMPLETED